Precise, reproducible flow cytometry solutions for robust phenotypical and functional analyses of your cell populations.
Characterize the full range of immune cell populations at the single-cell level with conventional and spectral flow cytometry solutions.
We operate a variety of leading flow platforms, with advanced data analytics to extract meaningful insight from complex datasets. Our scientists combine deep flow cytometry and immunology expertise to guide assay design, study planning, and data analysis.
All flow cytometry services are delivered in a GCLP environment across CAP-accredited, CLIA-certified laboratories.
Run studies using multiple advanced platforms, including:
Our flow cytometry services can be tailored to your study’s requirements. Whether we leverage the built-in audit trail of the BD FACSLyric for higher regulatory endpoints, or the high-parameter capability of the spectral Cytek Aurora platform, all depend on the specific needs of your program.
Our flow cytometry services can support a vast range of clinical samples, including:
Our team can provide guidance on sample stability and logistics, and offer in-house sample procurement, preparation, stimulation, or stabilization if needed.
Select from our pre-validated catalogue of panels for rapid flow implementation, or collaborate with our scientists to design a fully custom panels for a wide range of clinical immune monitoring endpoints.
Custom solutions can include:
Obtain fast, reliable results from complex flow cytometry datasets with CellEngine®, CellCarta's proprietary, cloud-based analysis software. Machine learning-assisted autogating reduces manual analysis time, metadata-driven workflows minimize human error, and supported UMAP/FlowSOM clustering can run in minutes, all within a 21 CFR 11-compliant environment.
Run studies using multiple advanced platforms, including:
Our flow cytometry services can be tailored to your study’s requirements. Whether we leverage the built-in audit trail of the BD FACSLyric for higher regulatory endpoints, or the high-parameter capability of the spectral Cytek Aurora platform, all depend on the specific needs of your program.
Our flow cytometry services can support a vast range of clinical samples, including:
Our team can provide guidance on sample stability and logistics, and offer in-house sample procurement, preparation, stimulation, or stabilization if needed.
Select from our pre-validated catalogue of panels for rapid flow implementation, or collaborate with our scientists to design a fully custom panels for a wide range of clinical immune monitoring endpoints.
Custom solutions can include:
Obtain fast, reliable results from complex flow cytometry datasets with CellEngine®, CellCarta's proprietary, cloud-based analysis software. Machine learning-assisted autogating reduces manual analysis time, metadata-driven workflows minimize human error, and supported UMAP/FlowSOM clustering can run in minutes, all within a 21 CFR 11-compliant environment.
Support your immune monitoring studies with our comprehensive list of off-the-shelf panels for whole blood and cryopreserved PBMC samples. Our OTS panels are pre-developed and validated at all global sites, providing the fastest runway to clinical sample analysis.
| Service | Application |
|---|---|
| Basophil Activation | Degranulation response assessment |
| Cell Enumeration | MDSC and CAR-T tracking |
| Cellular Proliferation | Track biological processes |
| Cellular Phenotyping | Subpopulation evaluation |
| Cell Sorting (FACs) | Achieving high cell purity |
| Intracellular Cytokine Staining | Functional cytokine profiling |
| Receptor Occupancy | PK/PD drug-target binding |
CellCarta conducted a fit-for-purpose, cross-validation of our enhanced TBNK assay across our global immune monitoring labs. By adding CD20 to detect B cells even when CD19 is masked by therapy, our workflow meets rigorous regulatory standards with consistent precision.
Combine our flow cytometry solutions with complementary immune-monitoring technologies for a more complete picture of immune response.
Measure antigen-specific cytokine-secreting cells at the single-cell level, a high-sensitivity complementary assay for vaccine, oncology, and autoimmune programs.
High-content analysis of up to 50 markers simultaneously, delivered in a GCLP environment.
Quantify critical soluble biomarkers with a benchmark technology; reliable, high-throughput, and validated for exploratory through primary endpoints.
As a platform-agnostic laboratory, we offer a range of multiparametric flow cytometry platforms for single-cell analysis, including, BD Lyric™, BD LSRFortessa™, Cytek™ Aurora, BD FACSAria II™, and CyTOF®. Our flow cytometry services cover the full range of immune monitoring applications, including cell enumeration, cellular phenotyping, cellular proliferation, intracellular cytokine staining, receptor occupancy, basophil activation testing, and fluorescence-activated cell sorting. Both pre-validated and custom panels are available for a range of clinical sample types, including cryopreserved PBMCs, whole blood, bone marrow aspirate, and cerebrospinal fluid.
Inter-site MFI variability is one of the most common challenges in multi-center flow cytometry studies. CellCarta addresses this through lyophilized bead-based instrument alignment, which has been used to standardize more than 10 assays across five global laboratory sites, achieving coefficients of variation below 30% across inter- and intra-site readouts. Off-the-shelf panels are pre-validated at all sites to the same standard, eliminating the need for per-site revalidation.
Yes. CellCarta’s global PBMC processing network operates across laboratories in Canada, the USA, Belgium, China, and Australia, with same-day processing capabilities and robust SOPs delivering greater than 95% cell viability. Our sample management services coordinate directly with clinical sites on shipping, sample tracking, and import and export requirements, achieving on-time study setup.
Yes. CellCarta offers a broad range of complementary technologies alongside flow cytometry solutions, including ELISpot and FluoroSpot for functional immune response monitoring, mass cytometry for higher-parameter phenotyping, ELISA for soluble biomarker quantification, genomics for transcriptomic context, and spatial biology for tissue-level immune profiling.
CellCarta uses CellEngine®, our proprietary cloud-based software for rapid, scalable data analysis across our flow cytometry services. Machine learning-assisted autogating reduces manual analysis time across large datasets, while metadata-driven workflows minimize human error. Batch comparisons, longitudinal study visualizations, and advanced clustering algorithms, including UMAP and FlowSOM, run in minutes rather than hours. CellEngine® operates in a 21 CFR 11-compliant environment.
